Carl Zeiss Meditec Invests in Sales Expansion in Spain
Acquisition of the surgical ophthalmology business assets of IMEX
Carl Zeiss Meditec's growth strategy is to provide comprehensive product solutions and excellent services to its customers. "Merging the sales forces of IMEX and Carl Zeiss Meditec in Spain enables us to offer diagnostic and surgical equipment, as well as the IOLs and OVDs for surgical ophthalmology procedures, to our Iberian customers from a single source," explains Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG. With the joint sales forces, Carl Zeiss Meditec will be able to establish a very strong, competitive team of ophthalmic experts in the market. Carl Zeiss Meditec will maintain the outstanding level of service and support both organizations are known for. Dr. Monz continues: "This approach will result in less complexity for customers as they will need to deal with only one partner." In addition, Carl Zeiss Meditec expects to improve its business performance through the replacement of the indirect sales channel.
Spain has always been an important market for Carl Zeiss Meditec, especially for the surgical ophthalmology business that was very successfully developed and expanded to Portugal by IMEX in recent years. With this acquisition, Carl Zeiss Meditec is strengthening its business, particularly in Spain, and systematically investing in its sales and service organization. "This step will enhance our market penetration and support future growth," concludes Dr. Ludwin Monz.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.